Literature DB >> 34713377

Encoding mu-opioid receptor biased agonism with interaction fingerprints.

R Bruno Hernández-Alvarado1, Abraham Madariaga-Mazón2, Fernando Cosme-Vela1, Andrés F Marmolejo-Valencia3, Adel Nefzi4,5, Karina Martinez-Mayorga6.   

Abstract

Opioids are potent painkillers, however, their therapeutic use requires close medical monitoring to diminish the risk of severe adverse effects. The G-protein biased agonists of the μ-opioid receptor (MOR) have shown safer therapeutic profiles than non-biased ligands. In this work, we performed extensive all-atom molecular dynamics simulations of two markedly biased ligands and a balanced reference molecule. From those simulations, we identified a protein-ligand interaction fingerprint that characterizes biased ligands. Then, we built and virtually screened a database containing 68,740 ligands with proven or potential GPCR agonistic activity. Exemplary molecules that fulfill the interacting pattern for biased agonism are showcased, illustrating the usefulness of this work for the search of biased MOR ligands and how this contributes to the understanding of MOR biased signaling.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Biased agonism; Biased factor; Herkinorin; Mu-opioid receptor; Protein–ligand interaction fingerprint; Virtual screening

Mesh:

Substances:

Year:  2021        PMID: 34713377     DOI: 10.1007/s10822-021-00422-5

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  54 in total

1.  Ligand-Specific Restriction of Extracellular Conformational Dynamics Constrains Signaling of the M2 Muscarinic Receptor.

Authors:  Marcel Bermudez; Andreas Bock; Fabian Krebs; Ulrike Holzgrabe; Klaus Mohr; Martin J Lohse; Gerhard Wolber
Journal:  ACS Chem Biol       Date:  2017-06-12       Impact factor: 5.100

2.  Computational insights into the G-protein-biased activation and inactivation mechanisms of the μ opioid receptor.

Authors:  Jian-Xin Cheng; Tao Cheng; Wei-Hua Li; Gui-Xia Liu; Wei-Liang Zhu; Yun Tang
Journal:  Acta Pharmacol Sin       Date:  2017-11-30       Impact factor: 6.150

3.  Residues W320 and Y328 within the binding site of the μ-opioid receptor influence opiate ligand bias.

Authors:  J Daniel Hothersall; Rubben Torella; Sian Humphreys; Monique Hooley; Alastair Brown; Gordon McMurray; Sarah A Nickolls
Journal:  Neuropharmacology       Date:  2017-03-07       Impact factor: 5.250

4.  Structural Basis for Ligand Recognition and Functional Selectivity at Angiotensin Receptor.

Authors:  Haitao Zhang; Hamiyet Unal; Russell Desnoyer; Gye Won Han; Nilkanth Patel; Vsevolod Katritch; Sadashiva S Karnik; Vadim Cherezov; Raymond C Stevens
Journal:  J Biol Chem       Date:  2015-09-29       Impact factor: 5.157

5.  Structural determinants of 5-HT2B receptor activation and biased agonism.

Authors:  John D McCorvy; Daniel Wacker; Sheng Wang; Bemnat Agegnehu; Jing Liu; Katherine Lansu; Alexandra R Tribo; Reid H J Olsen; Tao Che; Jian Jin; Bryan L Roth
Journal:  Nat Struct Mol Biol       Date:  2018-08-20       Impact factor: 15.369

Review 6.  Mu-Opioid receptor biased ligands: A safer and painless discovery of analgesics?

Authors:  Abraham Madariaga-Mazón; Andrés F Marmolejo-Valencia; Yangmei Li; Lawrence Toll; Richard A Houghten; Karina Martinez-Mayorga
Journal:  Drug Discov Today       Date:  2017-07-22       Impact factor: 7.851

7.  Characterization of Angiotensin II Molecular Determinants Involved in AT1 Receptor Functional Selectivity.

Authors:  Ivana Domazet; Brian J Holleran; Alexandra Richard; Camille Vandenberghe; Pierre Lavigne; Emanuel Escher; Richard Leduc; Gaétan Guillemette
Journal:  Mol Pharmacol       Date:  2015-03-25       Impact factor: 4.436

8.  Adrenaline-activated structure of β2-adrenoceptor stabilized by an engineered nanobody.

Authors:  Aaron M Ring; Aashish Manglik; Andrew C Kruse; Michael D Enos; William I Weis; K Christopher Garcia; Brian K Kobilka
Journal:  Nature       Date:  2013-09-22       Impact factor: 49.962

Review 9.  A comprehensive map of molecular drug targets.

Authors:  Rita Santos; Oleg Ursu; Anna Gaulton; A Patrícia Bento; Ramesh S Donadi; Cristian G Bologa; Anneli Karlsson; Bissan Al-Lazikani; Anne Hersey; Tudor I Oprea; John P Overington
Journal:  Nat Rev Drug Discov       Date:  2016-12-02       Impact factor: 84.694

10.  Exploring the repeat protein universe through computational protein design.

Authors:  T J Brunette; Fabio Parmeggiani; Po-Ssu Huang; Gira Bhabha; Damian C Ekiert; Susan E Tsutakawa; Greg L Hura; John A Tainer; David Baker
Journal:  Nature       Date:  2015-12-16       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.